About Ognomy
Ognomy is a Healthcare company based in New York (United States) founded in 2001 by Daniel Rifkin. Online platform offering video consultation services for sleep apnea management. Ognomy has raised $21.58 million across 3 funding rounds from investors including Inspire Medical, Impellent Ventures and Catalyst Investors. Its chief executive, as recorded, is Daniel Rifkin. Its website ognomy.com draws about 48 thousand monthly visits. Ognomy offers products and services including Video Consultation Service, Home Sleep Test, and Personalized Treatment Plan. Its focus areas include HealthTech, Disease Self Management, Sleep and Monitoring. Its legal entity is Ognomy, Inc. Its competitors include Stellar Sleep, Loona and GEM Health; 2 of its 3 listed competitors have raised funding.
Company details
Ognomy was founded in 2001 in New York, United States, as an online platform in the telemedicine sector. Video consultations with doctors are facilitated for sleep apnea management. Sleep tests are conducted from patients homes, and treatment plans are delivered based on diagnostic results. Operations are led by founder and CEO Daniel Rifkin, serving users across the United States in respiratory health services.
- Headquarters New York, United States
- Founders Daniel Rifkin
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ognomy.com
- Social LinkedIn X Facebook Instagram
- Legal Name Ognomy, Inc.
- Total Equity Funding$21.58M (USD)
in 3 rounds
- Latest Funding Round$20M (USD), Series A
May 2026
- InvestorsInspire Medical
& 6 more
Products & Services of Ognomy
Ognomy offers a comprehensive portfolio of products and services, including Video Consultation Service, Home Sleep Test, and Personalized Treatment Plan.
Enables remote consultations with sleep specialists for diagnosis.
At-home device for detecting sleep apnea through overnight monitoring.
Customized plans including CPAP and lifestyle advice for sleep care.
Apps and channels of Ognomy
Ognomy publishes 1 mobile app.
Funding Insights of Ognomy
Ognomy has successfully raised a total of $21.58M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $20 million completed in May 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $21.58M
- Total Rounds 3
- Last Round Series A — $20M
- Investors Count 7
All 3 funding rounds of Ognomy with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2026 | $20M | Series A | – | Catalyst Investors | |
| Aug 2024 | $1.58M | Seed | – | Impellent Ventures | – |
| Apr 2022 | Seed | – | Inspire Medical | – |
7 investors in total: 7 institutional.
Investors in Ognomy
Ognomy has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Inspire Medical, Impellent Ventures and Catalyst Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital funding is provided by Impellent Ventures. | impellent.vc | Rochester, United States | ||
| catalyst.com | ||||
| blueheroncap.com | ||||
| launchny.org | ||||
| upstatebiotechventures.com | ||||
Neurostimulation devices are developed to treat obstructive sleep apnea. | 2007 | inspiresleep.com | Maple Grove, United States | |
| buffalo.edu |
Investor details for Ognomy
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ognomy
14 people are tracked at Ognomy (9 in leadership, 3 in board & advisors, 2 in team).
| Name | Role | Group |
|---|---|---|
Daniel Rifkin | Founder & CEO | Leadership |
Folu Akinnusi | Chief Medical Officer | Leadership |
Tannay Chandhok | Head of Development | Leadership |
Ken Rosenfeld | COO | Leadership |
Thomas Schenk | Chief Strategy Officer | Leadership |
Pete Grandits | CFO | Leadership |
Kayla Fermoile | Head of Sheepa & Patient Services | Leadership |
Lisa W. | Director Of Clinical Operations | Leadership |
Alison Kole | Medical Director | Leadership |
Dimi Barot | Board Member | Board & advisors |
Greg Ross | Board Member | Board & advisors |
Naimish Patel | Board Member | Board & advisors |
Samantha Glanzer | Physician Success Champion | Team |
Sage Rifkin | Patient Care Coordinator | Team |
Complete people profiles for Ognomy
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ognomy
3 dated milestones of Ognomy across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Ognomy is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $20.0M.
Competitors of Ognomy
Ognomy has 3 listed competitors in our database, 2 of them funded. They include Stellar Sleep, Loona and GEM Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| stellarsleep.com | 2018 | Walnut, United States | $6.5M | Sleep quality is monitored through a specialized application. | ||
| loona.app | 2019 | Menlo Park, United States | Provider of an app for insomnia issue | |||
| gem.health | 2020 | Minneapolis, United States | $13.03M | 8 | Digital tools and support for sleep apnea treatment are provided. |
Detailed competitors of Ognomy
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ognomy
The website of Ognomy (ognomy.com) receives about 48.2K visits a month.
- Monthly visits48.2K
▼ 7.1% vs previous month
Websites whose visitors overlap most with Ognomy. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
wetreatsleep.com | wetreatsleep.com | 100% | #6,828,964 | – |
Top companies in Fitness & Wellness Platforms
3 companies that operate in the same segment as Ognomy (Fitness & Wellness Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,894 | |
Fitness class memberships are offered across various gyms and studios. | 2013 | New York, New York, United States | USD 550 M | 969 | ||
Subscription-based social networking platform for runners and cyclists | 2009 | San Francisco, California, United States | USD 180 M | 999 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ognomy
Complete news archive for Ognomy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ognomy
Ognomy was founded in 2001 and raised its 1st funding round 21 years after it was founded.
Ognomy is headquartered in New York, United States. It is registered at New York, New York, United States.
Daniel Rifkin is the CEO of Ognomy, as recorded in our data. They have also founded this company.
Ognomy is a funded company, having raised a total of $21.58M across 3 funding rounds to date.
Ognomy was founded in 2001 in New York, United States, as an online platform in the telemedicine sector. Video consultations with doctors are facilitated for sleep apnea management. Sleep tests are conducted from patients homes, and treatment plans are delivered based on diagnostic results. Operations are led by founder and CEO Daniel Rifkin, serving users across the United States in respiratory health services.
Ognomy's top competitors include Loona, GEM Health and Stellar Sleep.
Ognomy offers Video Consultation Service, Home Sleep Test, and Personalized Treatment Plan.
Ognomy has 7 investors. Key investors include Inspire Medical, Impellent Ventures, Catalyst Investors, Blue Heron Capital, and Launch NY.
Ognomy operates through Ognomy, Inc..
Yes. Ognomy publishes Ognomy - The Sleep Apnea App.